YTE reported $262.16M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Bristol Myers Squibb BMY:US $ 5712M 33M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Chemocentryx CCXI:US $ -20.8M 16.93M
Clovis Oncology CLVS:US $ -52.17M 0.97M
Cti Biopharma CTIC:US $ -23.25M 3.87M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Exelixis EXEL:US $ 56.42M 70.25M
Gilead Sciences GILD:US $ 4370M 1605M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Idera Pharmaceuticals IDRA:US $ -5.83M 0.53M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Macrogenics MGNX:US $ -50191000 12.69M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Moderna Inc MRNA:US 3.63B 497M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Newlink Genetics NLNK:US $ -7.49M 1.09M
Novartis NOVN:VX SF 4837M 65M
Novartis NVS:US $ 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M